The role of taxanes in triple-negative breast cancer: literature review [Corrigendum]
Mustacchi G, De Laurentiis MMustacchi G, De Laurentiis M. Drug Des Devel Ther. 2015;9:4303–4318.On page 4315, Disclosure section, "This work was supported by an unconditional grant from Editree editors, Italy, and both authors received a fee. Giorgio Mustacchi receives honoraria f...
Main Authors: | Mustacchi G, De Laurentiis M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | https://www.dovepress.com/corrigendum-the-role-of-taxanes-in-triple-negative-breast-cancer--peer-reviewed-article-DDDT |
Similar Items
-
The role of taxanes in triple-negative breast cancer: literature review
by: Mustacchi G, et al.
Published: (2015-08-01) -
Proteomic profiling identifies upregulation of aurora kinases causing resistance to taxane-type chemotherapy in triple negative breast cancer
by: Bohan Ning, et al.
Published: (2025-01-01) -
Triple Negative Breast Cancer-An Overview and Review of Literature
by: Amit Gupta
Published: (2013-02-01) -
Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study
by: Cheng Wang, et al.
Published: (2024-06-01) -
Efficacy and safety of taxanes combined with chemotherapy drugs in advanced triple negative breast cancer: A meta-analysis of 26 randomized controlled trials
by: Qionglian Huang, et al.
Published: (2022-08-01)